Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of IVAX Warfarin vs Coumadin in Healthy Males
NCT02171494Phase 1Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Sep 2008
- Primary completion
- Oct 2008
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, open-label trial of warfarin in thromboembolism (2 arms), sponsored by Boehringer Ingelheim. Primary endpoints: Area under the concentration-time curve from 0 to infinity and Maximum plasma concentration. Started Sep 2008; status: completed.
02
Drugs
warfarin
03
Conditions
thromboembolism
Beyond the preview
Go deeper on NCT02171494.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02171494.